Nasonex Sales Data

Rank 53 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Nasonex U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 53 (1) 5.67% -1.41%
Q3 2013 54 (10) -11.64% -19.59%
Q2 2013 44 (2) 2.75%
Q1 2013 46 (9) 8.87% 4.32%
Q4 2012 55 (6) 5.44% 3.12%
Q3 2012 61 (9) -9.30% -10.19%
Q2 2012 52 (4) -0.76% -2.48%
Q1 2012 56 (8) 9.21% 5.31%
Q4 2011 64 (4) 9.30% 8.08%
Q3 2011 68 (17) -14.77% -16.18%
Q2 2011 51 (4) 0.96% 0.75%
Q1 2011 55

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Watch this video series to learn about managing severe allergies (anaphylaxis).

Close
Hide
(web3)